[1]Patent:WO2003/93239,2003,A2.Locationinpatent:Page/Pagecolumn8
[2]Patent:WO2003/93239,2003,A2.Locationinpatent:Page/Pagecolumn10
[1]RSCAdvances,2017,vol.7,p.30453-30458
Title: Marcsisin SR, et al. Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malar J. 2014 Jan 3;13:2.